Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…
TruGolf to Paricipate in the 2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow Conference Presented by Maxim Group LLC on Wednesday, June 4th at 3:00 PM EDT
Salt Lake City, Utah, June 03, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings,…
